Switzerland· 65236002
Trulicity 0.75 mg, solution injectable stylo pré-remplie à usage unique
A dulaglutide product containing dulaglutidum, registered in Switzerland by Eli Lilly (Suisse) SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Dulaglutide is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BJ05 (dulaglutide), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Dulaglutide · ATC A10BJ05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dulaglutide costs, country by country.
Normalised to the WHO defined daily dose (0.16 mg), so markets compare like for like.
- Switzerland: $7.61 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Dulaglutide · price per daily dose (0.16 mg)
USD · FX 28 Sept 2026
- CH Switzerland$7.61
The record
At a glance
Swissmedic (Switzerland)- Active substance
- dulaglutidum
- Manufacturer
- Eli Lilly (Suisse) SA
- Country
- Switzerland (CH)
- ATC code
- A10BJ05
- ATC class
- Dulaglutide
- Defined daily dose
- 0.16 mg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806523600234 StkCHF 118.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
301 interactions on record for dulaglutide.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dulaglutide · interactions on record
301 records
- 3 severe
- 257 moderate
- 41 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dulaglutide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandTrulicityEli Lilly Nederland B.V.
- United StatesTrulicityEli Lilly and Company
- CzechiaTRULICITYEli Lilly Nederland B.V., Utrecht
- FinlandTrulicityEli Lilly Nederland B.V.
- NorwayTrulicityEli Lilly and Company Limited
- BelgiumTrulicity 0.75 mgEli Lilly Nederland
- United KingdomTrulicity 0.75mg/0.5ml solution for injection pre-filled pensEli Lilly and Company Ltd
- IcelandTrulicityEli Lilly Nederland B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Trulicity
- Liechtenstein · Trulicity
- Norway · Trulicity
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f65a29bd-91cf-4190-8166-94d6b2123f8a GET /v1/drugs/f65a29bd-91cf-4190-8166-94d6b2123f8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "dulaglutidum 0.75 mg",
"valid_from": "2015-06-01",
"limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus in Kombination mit folgenden Therapieoptionen, wenn durch diese Antidiabetika keine ausreichende Blutzuckerkontrolle erreicht wird:<br>\\n• Als Zweifachkombination mit Metformin, einem Sulfonythamstoff oder Pioglitazon<br>\\n• Als Dreifachkombination mit einer Kombination aus Metformin und einem Sulfonylhamstoff oder aus Metformin und Pioglitazon<br>\\n• in Kombination mit prandialem (kurzwirksamen) Insulin mit oder ohne Metformin<br>\\n• in Kombination mit Basalinsulin mit oder ohne Metformin<br>\\nMindestens BMI 28.<br>\\nZusätzliche Medikamente zur Gewichtsreduktion werden nicht vom Krankenversicherer vergütet.<br>\\n<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-01-01\"}]",
"galenic_form": "Inj Lös 0.75 mg/0.5ml Fertigpen",
"therapeutic_area": null,
"sl_inclusion_date": "2015-06-01",
"self_retention_pct": 10
}See everything about dulaglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.